TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
AGEN

Agenus Inc

Healthcare · Biotechnology

8.50$ +0.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Agenus Inc (AGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 227 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AGEN
Line item 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
56 128 94 89 140 133 104 73 45 57 46 31 20 35 35 75 242 157 138 136 155 215 466 414 314 226 227
48 102 64 63 93 93 67 42 21 35 32 21 12 23 28 43 184 91 74 75 87 114 332 213 112 46 133
46 96 61 33 57 16 33 24 14 24 20 20 11 21 27 40 172 76 60 53 62 100 292 179 76 40 3.0
46 99 61 59 89 87 62 40 19 34 30 20 11 21 27 40 172 76 60 53 62 100 307 193 76 40 3.0
– 0.5 0.5 1.1 0.6 0.1 0.0 0.2 0.3 0.6 0.8 0.0 0.5 0.6 0.0 1.2 9.8 11 1.1 0.9 16 1.2 1.5 2.7 26 0.4 1.8
– 0.7 1.4 1.0 0.9 0.2 0.3 0.4 0.5 0.2 0.3 0.0 0.0 0.0 0.7 0.1 0.1 0.1 0.1 0.1 7.4 11 20 14 0.0 – –
– 15 14 11 25 25 23 19 15 12 8.9 6.2 4.1 2.6 2.8 6.0 15 26 26 25 26 60 91 133 – – –
– 3.0 2.8 3,082 3,082 2,572 2,572 2.6 2.6 2.6 2.6 2.6 2.6 2.6 2.6 18 23 22 23 23 23 25 25 25 25 24 24
– 3.0 2.8 3.1 11 9.4 2.6 4.6 3.5 3.3 1.6 0.0 2.6 2.6 2.6 6.8 19 16 32 12 11 11 8.5 6.2 4.4 3.4 3.0
4.3 11 18 11 35 27 72 90 92 81 63 46 41 47 39 52 172 196 214 311 387 426 418 468 462 533 505
2.2 8.6 16 10.0 22 19 19 9.1 8.4 7.0 5.4 5.4 4.8 4.8 10 9.2 29 41 56 68 122 130 157 189 256 221 323
0.8 2.3 5.9 0.5 5.6 5.4 4.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 3.5 1.3 0.1 0.1 21 0.1 2.0 2.8 3.4 2.5 146 9.8 156
0.4 2.3 2.9 1.4 3.2 2.9 2.6 1.1 0.7 0.5 0.9 0.7 0.8 0.6 0.8 1.7 4.5 5.4 8.1 14 14 17 30 41 61 61 83
– 2.6 0.2 0.0 10 4.5 50 75 77 68 49 34 33 36 5.3 4.8 114 131 142 13 13 19 13 13 13 30 –
52 117 76 78 105 106 32 -17 -47 -24 -17 -15 -21 -12 -4.5 23 71 -39 -76 -175 -231 -211 48 -55 -148 -326 -271
-38 -84 -158 -214 -280 -336 -410 -462 -499 -527 -563 -584 -608 -619 -649 -691 -779 -905 -1,026 -1,177 -1,285 -1,466 -1,490 -1,710 -1,956 -2,183 -2,183
0.2 0.2 0.2 0.3 0.3 0.4 0.4 0.4 0.4 0.5 0.7 0.8 1.0 1.2 1.5 3.0 3.9 4.4 4.9 5.5 6.7 8.6 11 14 18 21 30

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?